Importance of oxidatively modified proteins in chronic renal failure

Kidney International, Supplement

Volumn 59, Issue 78, 2001, Pages

  Descamps Latscha, B ^a   Witko Sarsat, V ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Advanced oxidized protein products; Immunoinflammatory syndrome; Maintenance dialysis; Progression of uremia

Indexed keywords

OXIDIZING AGENT; ANTIOXIDANT; AUTACOID; BIOLOGICAL MARKER; PROTEIN;

CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; DIALYSIS; DISEASE COURSE; INFLAMMATION; MEDIATOR; MONOCYTE; NEUTROPHIL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN MODIFICATION; RESPIRATORY BURST; UREMIA; CHEMISTRY; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; PHAGOCYTE; REVIEW;

ANTIOXIDANTS; BIOLOGICAL MARKERS; HUMANS; INFLAMMATION MEDIATORS; KIDNEY FAILURE, CHRONIC; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHAGOCYTES; PROTEINS;

EID: 0035130258     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.59780108.x     Document Type: Conference Paper

References (44)

1. Oxidative stress in haemodialysis
2. Advanced oxidation protein products as a novel marker of oxidative stress in uremia
3. Advanced oxidation protein products as native mediators of inflammation and monocyte activation in chronic renal failure
4. Advanced oxidation protein products: Novel uraemic toxins and pro-inflammatory mediators in chronic renal failure?
5. Oxidative stress: Oxidants and antioxidants
6. Free radicals, antioxidents, and human disease: Where are we now?
7. The superoxide anion and singlet molecular oxygen: Their role in the microbicidal activity of the polymorphonuclear leukocytes
8. The biochemical basis of the NADPH oxidase of phagocytes
9. Oxygen metabolites from phagocytes
10. Nitric oxide as a secretory product of mammalian cells
11. Free radicals, lipids and protein degradation
12. Protein damage and degradation by oxygen radicals. I. General aspects
13. DNA damage and oxygen radical toxicity
14. Long-lived oxidants generated by human neutrophils: Characterization and bioactivity
15. Phagocytic leukocyte oxygenation activities and chemiluminescence: A kinetic approach to analysis
16. Protection against oxidants in biological systems: The superoxide theory of oxygen toxicity
17. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood
18. Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: A randomized prospective study
19. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis
20. Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis
21. Infection and immunity in end-stage renal disease patients
22. Erythrocyte glutathione peroxidase and superoxide dismutase activities in different stages of chronic renal failure
23. Correction of selenium deficiency in hemodialyzed patients
24. Glutathione that system as a marker of uremia progression and oxidative stress in chronic renal failure
25. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients
26. Vitamin C exhibits pro-oxidant properties
27. Does vitamin C have a pro-oxidant effect?
28. Antioxidant effects of a supplemented very low protein diet in chronic renal failure
29. Erythropoietin and oxidative stress in hemodialysis: Beneficial effects of vitamin E supplementation
30. Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter
31. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure
32. Lipid peroxidation abnormalities in hemodialyzed patients with chronic renal failure
33. Chemistry and biochemistry of 4- hydroxynonenal, malonaldehyde and related aldehydes
34. Influence of dialysis on plasma lipid peroxidation products and that levels
35. Biochemistry and pathology of radical- mediated protein oxidation
36. Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome
37. Dityrosine and tyrosine oxidation products are endogenous markers for the selective proteolysis of oxidatively modified red blood cell hemoglobin by the 19S proteasome
38. The oxidation of tyramine, tyrosine and related compounds by peroxidase
39. The advanced glycation endproduct pentosidine and monocyte activation in uremia
40. Structural modifications of human beta 2 microglobulin treated with oxygen-derived radicals
41. Serum advanced glycosylation end products: A new class of uremic toxins?
42. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure
43. Neutrophils: Molecules, functions and pathophysiological aspects